All News about Regeneron Pharmaceuticals
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
September 18, 2023
Via Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
September 14, 2023
Via Benzinga
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
Via Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Check Out What Whales Are Doing With REGN
September 08, 2023
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,000 Today
September 05, 2023
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
September 15, 2023
Via Benzinga
Check Out What Whales Are Doing With REGN
August 25, 2023
Via Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
August 22, 2023
Via Benzinga
Regeneron Provides Update on Planned Chief Financial Officer Transition
September 08, 2023
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
Regeneron Announces Investor Conference Presentations
August 23, 2023
Via GlobeNewswire
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.